Home » What we do » Publication Support » Drug and Clinical Trial Evaluations

Drug and Clinical Trial Evaluations

… is the most comprehensive review I have seen to date regarding the published data for this drug. The author should be congratulated on the effort, the manner in which it was presented and the expectation that this will become a valuable resource for the clinician.
Reader, University of Maryland

Overview

  • Available for the Expert Opinion series, the only review series to provide complete coverage of the pharmaceutical pipeline
  • Drug Evaluations available in five Expert Opinion titles; Clinical Trial Evaluations available in three Expert Opinion titles
  • Commissioned Drug and Clinical Trial Evaluations independently written by a recognized expert; Drug Evaluations validated by the same external peer-review process as the journal
  • Unsolicited Drug and Clinical Trial Evaluations also welcomed
  • Published within the journal and indexed on MEDLINE; can be summarised post-publication
  • Qualifies for FastTrack (5 to 7 weeks to online publication) and RapidTrack (10 to 12 weeks to online publication) services

Drug Evaluations

Drug Evaluations are a key feature of the Expert Opinion series. In short, Expert Opinion Drug Evaluations are 3,000-word articles presenting an evaluated overview of the clinical experience with, and efficacy of, a specific compound incorporating basic information on disease incidence and prevalence, unmet medical need, and present treatment guidelines (highlighting regional variations where appropriate).

Commissioned Drug Evaluations cover the following aspects:

  • Overview of the market
  • Introduction to the compound
  • Chemistry
  • Pharmacodynamics
  • Pharmacokinetics and metabolism
  • Clinical efficacy
  • Phase I studies
  • Phase II studies
  • Phase III studies
  • Post-marketing surveillance
  • Safety and tolerability
  • Regulatory affairs
  • Conclusion – an analysis of the data presented in the review
  • Expert Opinion

In order to add value to our commissioned Drug Evaluations, we take a collaborative approach throughout the writing process so authors have the opportunity to present new data to be included in the article if it meets our stringent editorial integrity criteria. Our experienced in-house publishing teams ensure timely publication and complete control over content management and scheduling, enabling fast turnaround at every stage of the publication process, without compromise.

Once your article is published, we can produce a summary to sit alongside the article, aiding comprehension and encouraging readership by busy professionals.

Available in:
Expert Opinion on Biological Therapy
Expert Opinion on Drug Metabolism & Toxicology
Expert Opinion on Drug Safety
Expert Opinion on Investigational Drugs
Expert Opinion on Pharmacotherapy

Clinical Trial Evaluations

Given the constraints on physicians’ time, Expert Opinion publishes short articles by practicing professionals that contextualize original research. Introduced last year, Expert Opinion Clinical Trial Evaluations are 1,500-word commentaries that analyze the design and impact of a pivotal study. Like Expert Opinion Drug Evaluations, they are independently written by a KOL in the field of the trial’s study and work in tandem with previously published research.

Commissioned Clinical Trial Evaluations cover the following aspects:

  • Introduction: The rationale behind the study
  • Study design: A description and discussion of the quality and appropriateness of the trial design
  • Key results: A summary and commentary of the key study results
  • Expert Opinion

The editorial team of Expert Opinion regularly commissions Clinical Trial Evaluations of major Phase III research for drugs and therapies that are emerging into the market. Provided that there is published peer-reviewed data on your trial, the team can commission an independent Clinical Trial Evaluation to supplement your existing research. Expert Opinion also publishes unsolicited Clinical Trial Evaluations subject to peer review.

As with our Drug Evaluations, we can produce a summary to sit alongside the article after publication. This summary can be hosted online and can be reprinted for your sales and congress presence.

Available in:
Expert Opinion on Biological Therapy
Expert Opinion on Investigational Drugs
Expert Opinion on Pharmacotherapy